Spermatech

Spermatech is a Norwegian biotechnology company dedicated to the development of innovative non-hormonal male contraceptives and diagnostic tools for male infertility. The company utilizes a proprietary drug discovery platform to identify sperm-specific proteins that are crucial for fertilization, ensuring high specificity and reducing the risk of off-target effects. Their primary research focuses on small molecule inhibitors that disrupt sperm motility and the sperm's ability to interact with the egg. By targeting unique physiological mechanisms within sperm cells, Spermatech seeks to provide reversible and effective reproductive health options for men. The company's approach is rooted in extensive academic research and aims to address a significant unmet need in the global contraceptive market.